$9.14
0.465.30%
At Close: -
$8.85
-0.29-3.20%
After Hours: 5:47 PM EDT
15 minutes delayed
Inovio Pharmaceuticals
INONASDAQ
Inovio Pharmaceuticals (NASDAQ:INO) Stock, Earnings Estimates, EPS, And Revenue
Inovio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-1.100
Quarterly Revenue Estimate
$120K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$717.1K
Analyze the earnings history of Inovio Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INO | Inovio Pharmaceuticals | -$1.56 | -$1.10 | — | — | $225.97K | $120.00K | — | — | 08/07/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.89 | -$1.00 | -$1.31 | -31.00% | $114.94K | — | $0.00 | — | 05/13/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$2.64 | -$1.27 | -$1.10 | 13.39% | $125.00K | $340.00K | $103.00K | -69.71% | 03/06/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.80 | -$1.56 | -$1.56 | 0.00% | $9.15M | $120.00K | $388.45K | 223.71% | 11/09/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$5.52 | -$1.68 | -$1.56 | 7.14% | $784.39K | $260.00K | $225.97K | -13.09% | 08/09/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.32 | -$1.68 | -$1.92 | -14.29% | $199.07K | $270.00K | $114.94K | -57.43% | 05/10/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$6.00 | -$2.04 | -$2.64 | -29.41% | $839.00K | $340.00K | $125.00K | -63.24% | 03/01/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.48 | -$3.60 | -$1.80 | 50.00% | $291.70K | $620.00K | $9.15M | 1376.45% | 11/08/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.68 | -$3.72 | -$5.52 | -48.39% | $272.82K | $520.00K | $784.39K | 50.85% | 08/09/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.24 | -$4.08 | -$4.32 | -5.88% | $371.12K | $670.00K | $199.07K | -70.29% | 05/10/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.68 | -$3.84 | -$6.00 | -56.25% | $5.58M | $2.84M | $839.00K | -70.46% | 03/01/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.12 | -$3.96 | -$3.48 | 12.12% | $236.18M | $970.00K | $291.70K | -69.93% | 11/09/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$2.40 | -$3.00 | -$4.68 | -56.00% | $267.19K | $1.21M | $272.82K | -77.45% | 08/09/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.12 | -$2.16 | -$3.24 | -50.00% | $1.33M | $850.00K | $371.12K | -56.34% | 05/10/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.56 | -$2.64 | -$1.68 | 36.36% | $279.00K | $1.11M | $5.58M | 402.79% | 03/01/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.00 | -$2.28 | -$3.12 | -36.84% | $866.86K | $3.05M | $236.18M | 7643.54% | 11/09/2020 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.60 | -$2.04 | -$2.40 | -17.65% | $135.67K | $2.61M | $267.19K | -89.76% | 08/10/2020 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.60 | -$2.64 | -$3.12 | -18.18% | $2.83M | $1.91M | $1.33M | -30.52% | 05/11/2020 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.08 | -$2.88 | -$4.56 | -58.33% | $2.50M | $2.32M | $279.00K | -87.97% | 03/12/2020 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.24 | -$3.12 | -$3.00 | 3.85% | $2.00M | $3.93M | $866.86K | -77.94% | 11/12/2019 | Get Alert |
| INO | Inovio Pharmaceuticals | -$0.96 | -$3.24 | -$3.60 | -11.11% | $24.45M | $5.66M | $135.67K | -97.60% | 08/08/2019 | Get Alert |
Inovio Pharmaceuticals (INO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $-1.31 | $-1.00 | -31.0 % |
| Dec 2023 | 2024-03-06 | $-1.10 | $-1.27 | 13.4 % |
| Sep 2023 | 2023-11-09 | $-1.56 | $-1.56 | 0.00 % |
| Jun 2023 | 2023-08-09 | $-1.56 | $-1.68 | 7.14 % |
Inovio Pharmaceuticals (INO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-06 | $103.00K | $340.00K | -69.7 % |
| Sep 2023 | 2023-11-09 | $388.45K | $120.00K | 223.7 % |
| Jun 2023 | 2023-08-09 | $225.97K | $260.00K | -13.1 % |
| Mar 2023 | 2023-05-10 | $114.94K | $270.00K | -57.4 % |
FAQ
When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?
Inovio Pharmaceuticals (INO) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Inovio Pharmaceuticals (NASDAQ:INO)?
The Actual EPS was $-1.31, which missed the estimate of $-1.00.
What were Inovio Pharmaceuticals’s (NASDAQ:INO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.